The FDA today approved the first non-opioid treatment designed to help manage the symptoms of opioid withdrawal in adults.
The drug, Lucemyra, isn’t a treatment for opioid use disorder, the agency noted. Instead, it is meant to be used as part of a broader plan to help adults manage their symptoms when they stop using opioids.
Get the full story at our sister site, Drug Delivery Business News.
The post FDA approves first non-opioid treatment for opioid withdrawal symptoms appeared first on MassDevice.